vindeburnol has been researched along with MS (Multiple Sclerosis) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braun, D; Feinstein, DL; Kalinin, S; Lin, SX; Polak, PE; Sharp, A | 1 |
1 other study(ies) available for vindeburnol and MS (Multiple Sclerosis)
Article | Year |
---|---|
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.
Topics: Animals; Cerebellum; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Image Processing, Computer-Assisted; Immunohistochemistry; Indicators and Reagents; Locus Coeruleus; Macrophage Activation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Norepinephrine; RNA, Messenger; Survival; T-Lymphocytes; Tyrosine 3-Monooxygenase; Vincamine | 2012 |